#KidneyCancer

#WorldCancerDay #UnitedByUnique #KidneyCancer

This multi-centre study of first-line treatment for metastatic kidney cancer aims to help oncologists around the world select the best treatment combination for each kidney cancer patient using a biomarker. www.youtube.com/watch?v=E_b6... #WorldCancerDay #UnitedByUnique #KidneyCancer (2/2)

AI in cancer care must be built with patients, not just for them.

#UnitedByUnique #TrustworthyAI #PatientCentredCare #COMFORT (7/7)

Because the question isn't just "does the model perform well?" It's "would a patient trust it?" (6/7)

Concretely, this means structured feedback sessions on AI explainability and transparency and patient involvement in model validation before clinical rollout. (5/7)

In the COMFORT project, the goal is to change that. Today, on World Cancer Day, we are highlighting our collaboration within the COMFORT consortium to bring real patient perspectives into how to build, evaluate, and deploy AI for cancer care. (4/7)

Most AI models in oncology are validated by researchers and clinicians. Patients, the people whose care depends on these tools, are rarely part of the process. (3/7)

We’re proud to support the COMFORT European Project (Computational Models FOR patienT stratification in urologic cancers), which aims to create a robust and trustworthy multimodal AI for health care. On #WorldCancerDay, learn more about the project in this video. (2/7)

However, according to the 4th Global Patient Survey, 62% of people were not asked by a healthcare professional to participate in a clinical trial.

Read the 2025 GPS Highlights Report at: ikcc.org/wp-content/u... #KidneyCancer (2/2)